Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo

Gastroenterology

Volumn 114, Issue 4 I, 1998, Pages 798-807

  Wagner, M ^a   Lopez, M E ^a   Cahn, M ^a   Korc, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031921301     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70594-3     Document Type: Article

References (51)

1. E Silverberg JA. Lubera Cancer Statistics 1989 CA Cancer J Clin 3 1989 3 39
2. AL Warshaw C. Fernades-Del Castillo Pancreatic carcinoma N Engl J Med 326 1992 455 465
3. M. Korc Conventional treatment of pancreatic cancer HG Beger MW Büchler P Malfertheiner Standards in pancreatic surgery. 1993 Springer-Verlag Berlin, Heidelberg 591 594
4. M Korc B Chandrasekar Yamanaka H Friess MW Büchler HG. Beger Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha J Clin Invest 90 1992 1352 1360
5. H Friess Y Yamanaka MS Kobrin DA Do MW Büchler M. Korc Enhanced erb B-3 expression in human pancreatic cancer correlates with tumor progression Clin Cancer Res 1 1995 1413 1420
6. Y Yamanaka H Friess MW Büchler HG Beger E Uchida M Onda MS Kobrin M. Korc Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage Cancer Res 53 1993 5289 5296
7. U Bergmann H Funatomi M Yokoyama HG Beger M. Korc Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles Cancer Res 55 1995 2007 2011
8. M Ebert M Yokoyama H Friess MW Büchler M. Korc Coexpression of the c- met proto-oncogene and hepatocyte-growth factor in human pancreatic cancer Cancer Res 54 1994 5775 5778
9. G Berrozpe I Schaeffer MA Peinado FX Real M. Perucho Comparative analysis of mutations in the p53 and K- ras genes in pancreatic cancer Int J Cancer 58 1994 185 191
10. T Urban S Ricci J-D Grange R Lacave F Boudghene F Breittmayer O Languille J Roland J-F. Bernaudin Detection of c-Ki- ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas J Natl Cancer Inst 85 1993 2008 2012
11. NS Pellegata F Sessa B Renault M Bonato BE Leone E Solcia GN. Ranzani K- ras and p53 mutations in pancreatic cancer: ductal and non-ductal tumors progress through different genetic lesions Cancer Res 54 1994 1556 1560
12. A Hoorens NR Lemoine E McLellan T Morohoshi T Kamisawa PU Heitz B Stamm J Ruschoff B Wiedenmann G. Kloppel Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki- ras mutation Am J Pathol 143 1993 385 398
13. SA Hahn M Schutte ATM Shanzul Hoque CA Moskaaluk LT da Costa A Fischer CJ Yeo RH Hruban SE. Kern DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 1996 350 353
14. M Yamasaki A Miyake S. Tagashira Y. Itoh Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family J Biol Chem 271 1996 15918 15921
15. A Basilico D. Moscatelli The FGF family of growth factors and oncogenes Adv Cancer Res 59 1992 115 165
16. CA MacArthur A Lawshe M Heikinheimo GM. Shackleford FGF-8 isoforms differ in NIH3T3 cell transforming potential Cell Growth Differ 6 1995 817 825
17. Y Li A Basilico A. Mansukhani Cell transformation by fibroblast growth factors can be suppressed by truncated fibroblast growth factor receptors Mol Cell Biol 14 1994 7660 7669
18. CA Dionne G Crumley F Bellot JM Kaplow G Searfoss M Ruta WH Burgess M Jaye J. Schlessinger Cloning and expression of two distinct high affinity receptors cross reacting with acidic and basic fibroblast growth factors EMBO J 9 1990 2685 2692
19. K Keegan DE Johnson LT Williarns MJ. Hayman Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3 Proc Natl Acad Sci USA 88 1991 1095 1099
20. J Partanen TP Makala E Eerola J Korhonen H Hirvonen L Claesson-Welsh K. Alitalo FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern EMBO J 10 1991 1347 1354
21. DE Johnson LT. Williams Structural and functional diversity of the FGF receptor multigene family Adv Cancer Res 60 1993 1 41
22. AT Chellaiah DG McEwen S Werner J Xu DM. Ornitz Fibroblast growth factor receptor (FGFR) 3 J Biol Chem 269 1994 11620 11627
23. HY Leung WJ Gullick NR. Lemoine Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer Int J Cancer 59 1994 667 675
24. I Siddiqi H Funatomi MS Kobrin H Friess MW Büchler M. Korc Increased expression of keratinocyte growth factor in human pancreatic cancer Biochem Biophys Res Commun 215 1995 309 315
25. RD Beauchamp RM Lyons EY Yang RJJ Coffey HL. Moses Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines Pancreas 5 1990 369 380
26. MS Kobrin Y Yamanaka H Friess ME Lopez M. Korc Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas Cancer Res 53 1993 4741 4744
27. SR Coughlin PJ Barr LS Cousens LJ Fretto LT. Williams Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo J Biol Chem 263 1988 983 988
28. J Schlessinger A. Ullrich Growth factor signaling by receptor tyrosine kinases Neuron 9 1992 383 391
29. FG Bellot J Crumley JM Kaplow J Schlessinger M Jaye CA. Dionne Ligand-induced trans-phosphorylation between different FGF receptors EMBO J 10 1991 2849 2854
30. M Mohammadi I Dikic A Sorokin WH Burgess M Jaye J. Schlessinger Identification of six novel autophosphorylation sites on fibroblast growth factor receptor I and elucidation of their importance in receptor activation and signal transduction Mol Cell Biol 16 1996 977 989
31. H Ueno Colbert JA Escobedo LT. Williams Inhibition of PDGF beta receptor signal transduction by coexpression of truncated receptor Science 252 1991 844 848
32. O Kashles Y Yarden R Fischer A Ullrich J. Schlessinger A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization Mol Cell Biol 11 1991 1454 1463
33. A Basu M Raghunath S Bishayee M. Das Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor kinase regulation Mol Cell Biol 9 1989 671 677
34. D Hsiang H Friess MW Büchler M Ebert I Butler M. Korc Absence of K- ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis Am J Surg 67 1997 264 268
35. M Mogaki M Hirota WG Chaney PM. Pour Comparison of p53 protein expression and cellular localization in human and hamster pancreatic cancer cell lines Carcinogenesis 14 1993 2584 2589
36. M Korc B Chandrasekar GN. Shah Differential binding and biological activities of epidermal growth factor and transforming growth factor alpha in a human pancreatic cancer cell line Cancer Res 51 1991 6243 6249
37. T Moriai MS Kobrin C Hope L Speck M. Korc A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling Proc Natl Acad Sci USA 91 1994 10217 10221
38. PB Mossmann LL. Young Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 65 1983 49 53
39. RL Baldwin M. Korc Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-l Growth Factors 8 1993 23 34
40. JJ Smith R Derynck M. Korc Production of transforming growth factor in human pancreatic cancer cell: evidence for a superagonist autocrine cycle Proc Natl Acad Sci USA 84 1987 7567 7570
41. J Wang W Han E Zbrowska J Liang X Wang JKV Willson L Sun MG. Brattain Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells J Biol Chem 271 1996 17366 17371
42. M Korc BE. Magun Recycling of epidermal growth factor in a human pancreatic carcinoma cell line Proc Natl Acad Sci USA 82 1985 6172 6175
43. Y Yamanaka H Friess MS Kobrin MW Büchler HG Beger M. Korc Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness Anticancer Res 13 1993 565 570
44. G Casey Y Yamanaka H Friess MS Kobrin ME Lopez MW Büchler HG Beger M. Korc p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis Cancer Lett 69 1993 151 160
45. C Almoguera D Shibata K Forrester J Martin N Arnheim M. Perucho Most human carcinomas of the exocrine pancreas contain mutant c-K- ras genes Cell 53 1988 549 554
46. CM Barton SL Staddon CM Hughes PA Hall C O'Sullivan G. Kloppel Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 64 1991 1076 1082
47. TP Yamaguchi K Harpal M Henkemeyer J. Rossant FGFR-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation Genes Dev 8 1994 3032 3044
48. H Ueno M Gunn K Dell AJ Tseng L. Williams A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptors J Biol Chem 267 1992 1470 1476
49. D Hanahan J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
50. E Levi R Fridman HQ Miao YS Ma A Yayon I. Vlodavsky Matrix metalloproteinase 2 releases active soluble ectodomain of fibro-blast growth factor receptor 1 Proc Natl Acad Sci USA 93 1996 7069 7074
51. A Estival V Monzat K Miquel F Gauber E Hollande M Korc N Vaysse F. Clemente Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability J Biol Chem 271 1996 5663 5670